Genmark Diagnostics

Genmark Diagnostics Rule of 40

Delisted

The Rule of 40 of Genmark Diagnostics (GNMK) as of Nov 2, 2026 is 84.08 %. In the previous year, Rule of 40 was -29.33 % — a change of -386.71% (higher).

Rule of 40

84.08 %

YoY

-386.71%

Last updated:

Rule of 40 of Genmark Diagnostics is 2020 84.08 % . Rule of 40 of Genmark Diagnostics was 2019 -29.33 % . It decreases by -386.71% higher compared to the previous year.

The Genmark Diagnostics Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2015
-76.57 USD
Jan 1, 2016
-77.46 USD
Jan 1, 2017
-110.99 USD
Jan 1, 2018
-36.44 USD
Jan 1, 2019
-29.33 USD
Jan 1, 2020
84.08 USD
The Genmark Diagnostics Rule of 40 history
YEARRule of 40YoY
84.08 %-386.71%
-29.33 %-19.53%
-36.44 %-67.17%
-110.99 %+43.28%
-77.46 %+1.17%
-76.57 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genmark Diagnostics Stock analysis

What does Genmark Diagnostics do? The company Genmark Diagnostics was founded in 1999 in California, USA. Its goal is to develop and produce diagnostic and testing solutions for the medical and biotechnology industries, with a focus on microfluidic technology. The company offers comprehensive services from the development of diagnostic and testing solutions to the production of devices and systems. Its main business areas are molecular diagnostics, laboratory test automation, and genomics. Genmark Diagnostics provides a variety of test solutions for diseases in the field of molecular diagnostics, as well as automation platforms for laboratory testing and products for genomic analysis. The company's products, such as the ePlex® system, aim to improve the accuracy and speed of medical diagnostics. Genmark Diagnostics is headquartered in Carlsbad, California, USA and has international branches. Its mission is to enhance the accuracy and speed of medical diagnostics worldwide through innovative devices and systems. Genmark Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmark Diagnostics stock

Rule of 40 of Genmark Diagnostics is 84.08 % in 2020.

On Eulerpool you can find the complete historical development of Rule of 40 Genmark Diagnostics since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Genmark Diagnostics

All Key Metrics — Genmark Diagnostics